Will LG Life Sciences & Sanofi’s lawsuit for ‘Zemiglo’ be prolonged?

Published: 2016-11-22 11:28:13

Updated: 2016-11-22 11:28:13

A trial for the Zemiglo’s license between LG Life Sciences and Sanofi Aventis seems to be prolonged.

The Seoul Central District Court’s Civil Affairs Department 17 conducted the 3^rd defense for the Sanofi Aventis’ damage claim suit against LG Life Sciences and Daewoong Pharmaceutical on the 18^th.

LG Life Sciences and Sanofi Aventis had sales activities for Zemiglo as signing a Korean co-mark...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.